GO:0003858 3-hydroxybutyrate dehydrogenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003858 defines the molecular function that catalyzes the reversible oxidation of (R)-3-hydroxybutanoate to acetoacetate, using NAD+ as the electron acceptor [1, 5].
• The enzyme is a member of the short-chain dehydrogenase/reductase family and is structurally characterized by a Rossmann-fold NAD(H)-binding domain and a catalytic tetrad.
• 3-hydroxybutyrate dehydrogenase activity is central to ketone body metabolism, influencing energy homeostasis in tissues such as brain, heart, liver, and intestine [2, 3, 7].
• Altered activity of this enzyme has been linked to diabetic cardiomyopathy and impaired ketone oxidation in heart mitochondria.
• Kinetic and structural studies reveal that the enzyme can function at sub-zero temperatures in psychrophilic organisms, highlighting its biotechnological potential.
• Research on this activity benefits from CRISPR-based knockout, knock-in, and overexpression models to dissect its role in metabolic and neurological disorders [6, 8].
Description
3-hydroxybutyrate dehydrogenase activity (GO:0003858) is a molecular function that catalyzes the reversible conversion of (R)-3-hydroxybutanoate to acetoacetate, coupled with the reduction of NAD+ to NADH [1, 5]. This reaction is a key step in ketone body metabolism, allowing tissues to utilize ketone bodies as an alternative energy source during periods of low glucose availability [2, 3]. The enzyme is widely distributed across species and tissues, with particularly high activity in liver, brain, heart, and intestine [2, 3, 7]. Researchers study this activity to understand metabolic flexibility, energy homeostasis, and the pathophysiology of conditions such as diabetes and neurodegeneration. The enzyme's ability to operate under extreme conditions, such as sub-zero temperatures in psychrophiles, also makes it a target for biotechnological applications. Structural and kinetic analyses have provided insights into its catalytic mechanism and regulation, offering a foundation for drug discovery and metabolic engineering.
3-hydroxybutyrate dehydrogenase activity At A Glance
| GO ID | GO:0003858 |
|---|---|
| GO term | 3-hydroxybutyrate dehydrogenase activity |
| Ontology | molecular_function |
| Synonym | D-beta-hydroxybutyrate dehydrogenase activity |
| Definition | Catalysis of the reaction: (R)-3-hydroxybutanoate + NAD+ = acetoacetate + H+ + NADH. |
| Major function | Reversible oxidation of (R)-3-hydroxybutanoate to acetoacetate, generating NADH. |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide) |
| Substrate | (R)-3-hydroxybutanoate (D-beta-hydroxybutyrate) |
| Product | Acetoacetate, H+, NADH |
| EC number | 1.1.1.30 |
| Related diseases | Diabetic cardiomyopathy, ketone body metabolism disorders |
What Is GO:0003858?
According to the Gene Ontology, GO:0003858 describes the catalysis of the reaction: (R)-3-hydroxybutanoate + NAD+ = acetoacetate + H+ + NADH. In other words, it is the enzyme activity that removes electrons from (R)-3-hydroxybutanoate (also known as D-beta-hydroxybutyrate) and transfers them to NAD+, producing acetoacetate and NADH. This activity is synonymous with D-beta-hydroxybutyrate dehydrogenase activity and is essential for ketone body interconversion [1, 5].
Why Is 3-hydroxybutyrate dehydrogenase activity Important in Cell Biology?
3-hydroxybutyrate dehydrogenase activity is critical for ketone body metabolism, which provides an alternative fuel for the brain, heart, and skeletal muscle during fasting or carbohydrate restriction [2, 3]. Dysregulation of this activity has been implicated in diabetic heart disease, where decreased ketone oxidation contributes to cardiac dysfunction. The enzyme also plays a role in the developing brain, as shown in chick embryos, suggesting importance in neurodevelopment. Furthermore, its ability to function at low temperatures in psychrophilic organisms offers insights into enzyme adaptation and potential industrial applications. Understanding this activity is therefore relevant to metabolic disorders, neurobiology, and biotechnology.
• Provides energy via ketone body oxidation in extrahepatic tissues such as brain and heart [2, 3].
• Its activity is reduced in heart mitochondria of diabetic rats, linking it to diabetic cardiomyopathy.
• Plays a role in brain development, as demonstrated in the developing chick brain.
• Contributes to ketone body utilization in the gastrointestinal tract, influencing nutrient absorption.
• Structural studies reveal a conserved catalytic mechanism that can be targeted for inhibitor design.
• Kinetic characterization at sub-zero temperatures informs protein engineering for cold-active biocatalysts.
• The enzyme is a potential biomarker for metabolic flexibility and ketosis.
• Its activity can be modulated by nutritional and hormonal states, affecting whole-body energy homeostasis [2, 3].
Molecular Mechanism of 3-hydroxybutyrate dehydrogenase activity
Substrate Binding and Orientation
In simple terms: The enzyme grabs the substrate and positions it perfectly for a chemical reaction.
The enzyme binds (R)-3-hydroxybutanoate in a specific pocket that orients the hydroxyl group toward the catalytic residues and the NAD+ cofactor. Structural studies of D-3-hydroxybutyrate dehydrogenase have revealed that a conserved arginine and a serine residue form hydrogen bonds with the substrate's carboxylate and hydroxyl groups, ensuring precise positioning for hydride transfer. This binding step is essential for catalysis and is highly stereospecific for the (R)-enantiomer.
Hydride Transfer and Catalysis
In simple terms: A tiny particle (hydride) is moved from the substrate to NAD+, turning it into NADH.
The catalytic mechanism involves a direct hydride transfer from the C3 of (R)-3-hydroxybutanoate to the nicotinamide ring of NAD+. Kinetic isotope effect studies and transition state analyses have shown that this step is rate-limiting and involves a concerted motion of the substrate and cofactor. The reaction is reversible, allowing the enzyme to also catalyze the reduction of acetoacetate to (R)-3-hydroxybutanoate under physiological conditions.
Cofactor Regeneration and Release
In simple terms: After the reaction, the enzyme releases the products and gets ready for another round.
Following hydride transfer, NADH and acetoacetate are released from the active site. The enzyme undergoes conformational changes that facilitate product release and allow NAD+ to rebind. This step is influenced by the redox state of the cell and the availability of substrates. The overall reaction is reversible, with the equilibrium favoring either direction depending on the concentrations of substrates and products.
Structural Determinants of Activity
In simple terms: The enzyme's 3D shape determines how well it works.
The enzyme belongs to the short-chain dehydrogenase/reductase (SDR) family and features a Rossmann-fold domain for NAD+ binding and a catalytic tetrad (Asn, Ser, Tyr, Lys) that stabilizes the transition state. Mutations in these residues drastically reduce activity, as shown by site-directed mutagenesis and crystallographic studies. The enzyme's oligomeric state and membrane association can also affect its activity in vivo.
Regulation by Cellular Environment
In simple terms: The cell can speed up or slow down this enzyme based on its needs.
Enzyme activity is regulated by the availability of NAD+ and NADH, as well as by the concentrations of ketone bodies. In diabetic heart mitochondria, decreased activity of D-3-hydroxybutyrate dehydrogenase is associated with impaired ketone oxidation, suggesting that metabolic stress can downregulate the enzyme. Additionally, developmental and nutritional states can influence enzyme levels, as seen in the developing chick brain and in ketonaemic sheep [2, 3].
Key Genes Involved in GO:0003858 3-hydroxybutyrate dehydrogenase activity
The following genes and proteins are directly or indirectly associated with 3-hydroxybutyrate dehydrogenase activity, based on experimental evidence from the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BDH1 | Encodes D-3-hydroxybutyrate dehydrogenase, the primary enzyme for ketone body oxidation | Target for studying ketone metabolism in heart, brain, and liver [6, 8] |
| BDH2 | Encodes a related dehydrogenase with preference for 3-hydroxybutyrate | Potential role in ketone body metabolism and cellular stress responses |
| HADH | Short-chain dehydrogenase involved in fatty acid oxidation | May share structural and functional similarities with BDH1 |
| ACAT1 | Acetoacetyl-CoA thiolase, involved in ketone body synthesis | Upstream of BDH1 in ketone body interconversion |
| OXCT1 | Succinyl-CoA:3-oxoacid CoA-transferase, required for ketone body utilization | Works in concert with BDH1 for ketone oxidation |
| SLC16A1 | Monocarboxylate transporter 1, transports ketone bodies | Regulates substrate availability for BDH1 |
| SLC16A7 | Monocarboxylate transporter 2, transports ketone bodies | Expressed in brain and heart, affecting BDH1 activity |
| PPARA | Peroxisome proliferator-activated receptor alpha, regulates lipid metabolism | May influence BDH1 expression during fasting |
| FOXO1 | Forkhead box O1, transcription factor | Potential regulator of BDH1 in response to nutrient stress |
| PGC1A | PPARG coactivator 1 alpha, mitochondrial biogenesis | Linked to increased ketone oxidation capacity |
| INS | Insulin | Regulates ketone body metabolism and BDH1 activity |
| GCK | Glucokinase | Influences glucose availability and ketone body use |
| CPT1A | Carnitine palmitoyltransferase 1A | Fatty acid oxidation, indirectly affects ketone body levels |
| HMGCS2 | HMG-CoA synthase 2, ketogenesis | Produces ketone bodies that are substrates for BDH1 |
| HMGCL | HMG-CoA lyase, ketogenesis | Generates acetoacetate, which BDH1 can reduce |
| SIRT3 | Sirtuin 3, mitochondrial deacetylase | May regulate BDH1 activity via deacetylation |
| AMPK | AMP-activated protein kinase | Energy sensor that can modulate ketone metabolism |
| MTOR | Mechanistic target of rapamycin | Regulates cell growth and metabolism, potential indirect regulator |
How Is 3-hydroxybutyrate dehydrogenase activity Regulated?
The activity of 3-hydroxybutyrate dehydrogenase is regulated at multiple levels. Acutely, the enzyme's activity depends on the availability of NAD+ and the concentrations of ketone bodies, which fluctuate with nutritional state. In diabetic heart mitochondria, decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase leads to reduced ketone oxidation, suggesting that metabolic stress can downregulate the enzyme. Hormonal signals such as insulin and glucagon also influence ketone body metabolism, indirectly affecting enzyme activity. Additionally, developmental cues regulate enzyme levels in the brain, as shown in the developing chick. At the molecular level, post-translational modifications such as acetylation may modulate activity, though direct evidence for BDH1 acetylation is still emerging.
3-hydroxybutyrate dehydrogenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BDH1 | Diabetic cardiomyopathy | Knockout mouse, heart-specific overexpression |
| BDH1 | Ketone body metabolism disorders | Point mutation knock-in in cell lines |
| BDH2 | 3-hydroxyisobutyrate dehydrogenase impurity | CRISPR knockout in HEK293 |
| OXCT1 | Succinyl-CoA:3-oxoacid CoA-transferase deficiency | Knockout zebrafish or mouse |
| SLC16A1 | Monocarboxylate transporter 1 deficiency | Knock-in of patient mutations |
Diabetic Cardiomyopathy
In diabetic rats, heart mitochondria exhibit decreased rates of ketone body oxidation and reduced activity of D-3-hydroxybutyrate dehydrogenase. This impairment contributes to cardiac energy deficiency and contractile dysfunction, highlighting the enzyme as a potential therapeutic target for diabetic heart disease.
Neurological Disorders
The brain relies on ketone bodies as an alternative fuel during fasting or ketogenic diets. 3-hydroxybutyrate dehydrogenase activity is present in brain mitochondria and varies during development. Alterations in this activity could affect neuronal energy metabolism and may be relevant to neurodegenerative conditions, although direct evidence is still limited.
Metabolic Syndrome and Ketosis
In sheep, ketonaemia is associated with changes in 3-hydroxybutyrate dehydrogenase activity in tissues, suggesting a role in whole-body ketone homeostasis. Dysregulation of this enzyme may contribute to metabolic inflexibility observed in obesity and type 2 diabetes [2, 8].
From 3-hydroxybutyrate dehydrogenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BDH1 loss impair ketone oxidation in heart? | BDH1 knockout mouse or CRISPR KO in cardiomyocytes |
| How do point mutations affect catalytic efficiency? | Site-directed mutagenesis and knock-in cell lines |
| Can BDH1 overexpression protect against diabetic cardiomyopathy? | AAV-mediated overexpression in diabetic rat heart |
| What is the role of BDH1 in brain development? | Chick embryo knockdown or KO |
| Does BDH1 acetylation regulate its activity? | Knock-in of acetylation-mimetic mutants |
| Can BDH1 be targeted for cold-active biocatalysis? | Directed evolution and expression in psychrophilic hosts |
How to Study the 3-hydroxybutyrate dehydrogenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric NADH assay | Enzyme activity | Tissue distribution and kinetic studies [2, 3] |
| X-ray crystallography | 3D structure | Catalytic mechanism and inhibitor design |
| Kinetic isotope effects | Transition state and rate-limiting steps | Enzyme mechanism and cold adaptation |
| CRISPR knockout | Gene function | Loss-of-function studies in cells and animals |
| Site-directed mutagenesis | Residue-specific effects | Catalytic tetrad validation |
| Western blot | Protein expression | Correlating activity with protein levels |
| RNA-seq | Transcriptional regulation | Identifying regulators of BDH1 expression |
| Metabolomics | Ketone body levels | Linking enzyme activity to metabolic flux |
Enzymatic Activity Assays
The most direct method to measure 3-hydroxybutyrate dehydrogenase activity is a spectrophotometric assay that monitors the reduction of NAD+ to NADH at 340 nm. This assay can be performed on tissue homogenates or purified enzyme and is used to quantify activity in different tissues and conditions [2, 3, 7].
Structural Biology
X-ray crystallography and cryo-electron microscopy have been used to determine the three-dimensional structure of D-3-hydroxybutyrate dehydrogenase, revealing the catalytic tetrad and NAD+ binding site. These methods are essential for understanding the mechanism and for structure-based drug design.
Kinetic Isotope Effects
Kinetic isotope effect experiments, such as measuring the rate of hydride transfer with deuterated substrates, provide insights into the transition state and rate-limiting steps of the reaction. These studies are particularly useful for comparing psychrophilic and mesophilic enzyme variants.
CRISPR-Based Genetic Models
CRISPR/Cas9 knockout, knock-in, and overexpression models allow researchers to dissect the physiological roles of BDH1 and related genes. For example, knockout of BDH1 in cell lines or animal models can reveal its contribution to ketone body metabolism and disease [6, 8].
How CRISPR Can Be Used to Study GO:0003858 3-hydroxybutyrate dehydrogenase activity
Knockout
CRISPR/Cas9-mediated knockout of BDH1 or related genes can abolish 3-hydroxybutyrate dehydrogenase activity, allowing researchers to study the consequences for ketone body metabolism, energy homeostasis, and disease progression. For example, BDH1 knockout in cardiomyocytes can reveal its role in diabetic cardiomyopathy.
Point Mutation
Introducing point mutations in the catalytic tetrad of BDH1 (e.g., Ser, Tyr, Lys) via CRISPR knock-in can dissect the contribution of individual residues to catalysis. Such models are valuable for validating structural findings and for understanding disease-associated mutations.
Knock-in
Knock-in of tagged BDH1 (e.g., FLAG or GFP) enables affinity purification and live-cell imaging, facilitating studies of protein localization, interactions, and dynamics. Knock-in of patient-derived mutations can also model disease phenotypes in isogenic cell lines.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of BDH1 can increase 3-hydroxybutyrate dehydrogenase activity, allowing researchers to test whether enhanced ketone oxidation protects against metabolic stress or improves cardiac function.
How EDITGENE Supports 3-hydroxybutyrate dehydrogenase activity Research
Researchers studying 3-hydroxybutyrate dehydrogenase activity-related genes often need to determine whether a candidate gene is causally involved in ketone body metabolism, metabolic disease, or neurodevelopment. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for 3-hydroxybutyrate dehydrogenase activity research.
Frequently Asked Questions About 3-hydroxybutyrate dehydrogenase activity
What is 3-hydroxybutyrate dehydrogenase activity?
It is the enzyme activity that catalyzes the reversible conversion of (R)-3-hydroxybutanoate to acetoacetate, using NAD+ as a cofactor, as defined by GO:0003858 [1, 5].
What genes are involved in 3-hydroxybutyrate dehydrogenase activity?
The primary gene is BDH1, which encodes D-3-hydroxybutyrate dehydrogenase. Related genes include BDH2, OXCT1, and ACAT1, which are involved in ketone body metabolism [4, 6, 8].
What is the role of BDH1 in ketone body metabolism?
BDH1 catalyzes the first step in ketone body oxidation, converting (R)-3-hydroxybutanoate to acetoacetate, which can then enter the TCA cycle for energy production [6, 8].
How is 3-hydroxybutyrate dehydrogenase activity measured?
It is typically measured using a spectrophotometric assay that monitors NADH production at 340 nm, or by kinetic isotope effect studies for mechanistic insights [2, 5].
What diseases are associated with 3-hydroxybutyrate dehydrogenase activity?
Decreased activity has been linked to diabetic cardiomyopathy and impaired ketone oxidation in heart mitochondria. It may also play a role in neurological disorders and metabolic syndrome [2, 3].
Can CRISPR be used to study 3-hydroxybutyrate dehydrogenase activity?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the function of BDH1 and related genes in cells and animal models [6, 8].
What is the catalytic mechanism of 3-hydroxybutyrate dehydrogenase?
The enzyme uses a hydride transfer mechanism, moving a hydride from the substrate to NAD+, facilitated by a catalytic tetrad of Asn, Ser, Tyr, and Lys residues [5, 6].
Is 3-hydroxybutyrate dehydrogenase activity reversible?
Yes, the reaction is reversible; the enzyme can both oxidize (R)-3-hydroxybutanoate to acetoacetate and reduce acetoacetate back to (R)-3-hydroxybutanoate.
What is the difference between BDH1 and BDH2?
BDH1 is the primary mitochondrial enzyme for ketone body oxidation, while BDH2 is a related dehydrogenase with different substrate specificity and tissue distribution.
How does diabetes affect 3-hydroxybutyrate dehydrogenase activity?
In diabetic rats, heart mitochondria show decreased D-3-hydroxybutyrate dehydrogenase activity, contributing to impaired ketone oxidation and cardiac dysfunction.
Conclusion
3-hydroxybutyrate dehydrogenase activity (GO:0003858) is a fundamental molecular function in ketone body metabolism, with critical roles in energy homeostasis, development, and disease. Its dysregulation is implicated in diabetic cardiomyopathy and potentially other metabolic and neurological conditions. Structural and kinetic studies have elucidated its catalytic mechanism, providing a basis for therapeutic targeting [5, 6]. CRISPR-based models offer powerful tools to further dissect its physiological and pathological roles, and EDITGENE is well-positioned to support such research with custom gene editing services.
References
- 1. Taxon ES et al.. 2020. Kinetics aspects of Gamma-hydroxybutyrate dehydrogenase.. Biochim Biophys Acta Proteins Proteom 1868(5):140376 PMID: 31981617
- 2. Watson HR et al.. 1972. 3-hydroxybutyrate dehydrogenase in tissues from normal and ketonaemic sheep.. Biochem J 128(1):53-7 PMID: 5085631
- 3. Nehlig A et al.. 1980. Variations of 3-hydroxybutyrate dehydrogenase activity in brain and liver mitochondria of the developing chick.. Biochim Biophys Acta 633(1):22-32 PMID: 7448204
- 4. Worrall EB et al.. 1987. 3-Hydroxyisobutyrate dehydrogenase, an impurity in commercial 3-hydroxybutyrate dehydrogenase.. Biochem J 241(1):297-300 PMID: 3494445
- 5. Machado TFG et al.. 2021. Transition States for Psychrophilic and Mesophilic (R)-3-Hydroxybutyrate Dehydrogenase-Catalyzed Hydride Transfer at Sub-zero Temperatures.. Biochemistry 60(27):2186-2194 PMID: 34190541
- 6. Kanazawa H et al.. 2016. Structural insights into the catalytic reaction trigger and inhibition of D-3-hydroxybutyrate dehydrogenase.. Acta Crystallogr F Struct Biol Commun 72(Pt 7):507-15 PMID: 27380367
- 7. Hanson PJ et al.. 1981. Activity of 3-oxo acid CoA-transferase, D-3-hydroxybutyrate dehydrogenase, hexokinase and carnitine palmitoyltransferase in the stomach and small and large intestine of the rat.. Biochem J 200(2):349-55 PMID: 6951579
- 8. Grinblat L et al.. 1986. Decreased rate of ketone-body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats.. Biochem J 240(1):49-56 PMID: 3548709
